Search details
1.
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activity.
Nature
; 570(7761): E53, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-31142845
2.
Design of amidobenzimidazole STING receptor agonists with systemic activity.
Nature
; 564(7736): 439-443, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30405246
3.
3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists.
Bioorg Med Chem Lett
; 20(2): 521-5, 2010 Jan 15.
Article
in English
| MEDLINE | ID: mdl-20005711
4.
4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonists.
Bioorg Med Chem Lett
; 20(1): 209-12, 2010 Jan 01.
Article
in English
| MEDLINE | ID: mdl-19932617
5.
Correction to Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel.
ACS Med Chem Lett
; 11(6): 1353, 2020 Jun 11.
Article
in English
| MEDLINE | ID: mdl-32551024
6.
Biarylether amide quinolines as liver X receptor agonists.
Bioorg Med Chem
; 17(4): 1663-70, 2009 Feb 15.
Article
in English
| MEDLINE | ID: mdl-19162487
7.
4-(3-aryloxyaryl)quinoline alcohols are liver X receptor agonists.
Bioorg Med Chem
; 17(23): 8086-92, 2009 Dec 01.
Article
in English
| MEDLINE | ID: mdl-19853462
8.
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel.
ACS Med Chem Lett
; 9(10): 1039-1044, 2018 Oct 11.
Article
in English
| MEDLINE | ID: mdl-30344914
9.
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases.
J Med Chem
; 60(4): 1247-1261, 2017 02 23.
Article
in English
| MEDLINE | ID: mdl-28151659
10.
Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.
J Med Chem
; 49(21): 6151-4, 2006 Oct 19.
Article
in English
| MEDLINE | ID: mdl-17034119
11.
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase.
J Med Chem
; 59(10): 4867-80, 2016 05 26.
Article
in English
| MEDLINE | ID: mdl-27109867
12.
Synthesis of 1-Amino-3-[2-(1,7-dicarba-closo-dodecaboran(12)-1-yl)ethyl]cyclobutanecarboxylic Acid: A Potential BNCT Agent.
J Org Chem
; 62(13): 4476-4478, 1997 Jun 27.
Article
in English
| MEDLINE | ID: mdl-11671777
13.
Estrogen receptor beta ligands: design and synthesis of new 2-phenyl-isoindole-1,3-diones.
Bioorg Med Chem Lett
; 17(1): 118-22, 2007 Jan 01.
Article
in English
| MEDLINE | ID: mdl-17049855
14.
Further modification on phenyl acetic acid based quinolines as liver X receptor modulators.
Bioorg Med Chem
; 15(10): 3321-33, 2007 May 15.
Article
in English
| MEDLINE | ID: mdl-17391964
Results
1 -
14
de 14
1
Next >
>>